12:00 AM
 | 
Aug 17, 2009
 |  BC Week In Review  |  Company News  |  Deals

Nanosphere, Eli Lilly deal

Eli Lilly and Nanosphere will develop pharmacogenetic assays to predict patient responses for undisclosed...

Read the full 48 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >